Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term pain modulation by intravenous esketamine in Complex Regional Pain Syndrome
2021-000640-21Phase 4Active
- Sponsor
- Center for Pain Medicine
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in complex regional pain syndrome (CRPS) (2 arms), sponsored by Center for Pain Medicine. Primary endpoint: Pain intensity (Numerical Rating Scale). Started Aug 2021; status: active.
02
Drugs
esketamine
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on 2021-000640-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000640-21.